| Institution: | 1. EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University Salzburg, Müllner Hauptstraße 48, 5020 Salzburg, Austria;2. Institute for Transfusion Medicine and Gene Therapy, Medical Center – University of Freiburg, Freiburg, Germany;3. Center for Chronic Immunodeficiency, Medical Center – University of Freiburg, Freiburg, Germany;4. Cell Therapy Institute, SCI-TReCS, Paracelsus Medical University, Salzburg, Austria;5. Epithelial Biomedicine Division, CIEMAT-CIBERER, Department of Bioengineering, UC3M, Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz, 28040 Madrid, Spain;6. Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University Salzburg, 5020 Salzburg, Austria;7. Faculty of Medicine, University of Freiburg, Freiburg, Germany |
